Research output per year
Research output per year
Personal profile
Expertises
Inge Marie Svane has 25 years of research experience in cancer immunology and immunotherapy and holds a PhD in basic cancer immunology and a professorship in clinical cancer immunotherapy. She has pioneered the field of cancer immunotherapy in Denmark building up CCIT, a translational research center in European leading position. Focus of expertise is T-cell based adoptive cell therapy and other cellular therapies, cancer vaccines, and immune regulation.
Main research areas
Since 2001 she has initiated 15 phase I, II and III immunotherapeutic trials as Sponsor. She is national principal /investigator on numerous international clinical trials in collaboration with pharmaceutical industry primarily within the area of immunotherapy.
Current research
For ongoing clinical protocols, please check our website
https://www.herlevhospital.dk/ccit-denmark/research/Sider/Clinical-protocols.aspx
Potential conflicts of interest
Cooperation with medical companies within Clinical Cancer Research
Co-founder of IO Biotech ApS
Fingerprint
Dive into the research topics where Inge Marie Svane is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., El Fassi, D., Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 2023, In: Frontiers in Immunology. 14, p. 1117466 1117466.Research output: Contribution to journal › Journal article › Research › peer-review
-
ASO Visual Abstract: Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma-A National Cohort Study of 1480 Patients
Helvind, N. M., Weitemeyer, M. B-M., Chakera, A. H., Hendel, H. W., Ellebæk, E., Svane, I. M., Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, C., Bidstrup, P. E. & Hölmich, L. R., Apr 2023, In: Annals of Surgical Oncology. 30, p. 2389–2390Research output: Contribution to journal › Editorial › peer-review
-
Combination therapy with immune check point inhibitors and acute kidney injury
Valentin, A., Møller, A. K. H., Palshof, J. A., Broberg, B., Gravesen, E., Svane, I. M. & Hansen, D., 8 Feb 2023, (E-pub ahead of print) In: Acta Oncologica. p. 1-5 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients
Helvind, N. M., Weitemeyer, M. B-M., Chakera, A. H., Hendel, H. W., Ellebæk, E., Svane, I. M., Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, C., Bidstrup, P. E. & Hölmich, L. R., 8 Feb 2023, (E-pub ahead of print) In: Annals of Surgical Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
-
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply
Dahl, E. K., Abed, O. K., Kjeldsen, J., Donia, M., Svane, I. M., Dige, A., Agnholt, J. S., Bjerrum, J. T. & Seidelin, J. B., Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 152-153 2 p.Research output: Contribution to journal › Editorial › peer-review